The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background. Elevated plasma low-density lipoprotein cholesterol (LDL-C) is the main risk factor for atherosclerotic cardiovascular disease (ASCVD). Statins are the drugs of choice for decreasing LDL-C and are used for the prevention and management of ASCVD. Guidelines recommend that subjects with hi...
Main Authors: | Tannaz Jamialahmadi, Fatemeh Baratzadeh, Željko Reiner, Luis E. Simental-Mendía, Suowen Xu, Andrey V. Susekov, Raul D. Santos, Amirhossein Sahebkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/9661752 |
Similar Items
-
Effects of Statins on Renin–Angiotensin System
by: Nasim Kiaie, et al.
Published: (2021-07-01) -
Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
by: Homa Nomani, et al.
Published: (2021-02-01) -
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
by: Na-Qiong Wu, et al.
Published: (2018-11-01) -
Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01) -
Hydrophilic or Lipophilic Statins?
by: Elisenda Climent, et al.
Published: (2021-05-01)